12 to 20 Plus acquisition
This article was originally published in The Tan Sheet
Executive Summary
Purchase of Neurochemical Research Corporation by 12 to 20 Plus announced Oct. 2. San Luis Obispo, Calif.-based firm now holds NRC's "line of technically sophisticated dietary supplements," including: ChemoKare, which possesses ingredients that "significantly inhibit and even kill human cancer cells;" QuitSystem for recovering alcoholics and drug abusers to repair "dramatically impaired brain chemistry;" and Anaplex, a "drug-free and non-herbal treatment for anxiety and depression." Three years following acquisition, combined firm expects annual sales volume to surpass $30 mil. Line will be sold under new division called Neurochemical Research Group...